Title : Innovations in DNA and RNA vaccine technology their impact on treatment efficacy and delivery
Abstract:
Advances in genetic engineering vaccines have made DNA vaccines a highly promising option for hereditary and acquired illnesses. The main obstacle; nevertheless, is the absence of an ideal delivery system, which severely restricts DNA vaccines' capacity to generate an immune response. Furthermore, the recent emergence of SARS-CoV-2 vaccines has shifted attention towards RNA vaccines, especially mRNA vaccines.
Based on recent research, the goal of this study is to present a thorough overview and analysis of the current status and limitations of vaccines. It discusses and organize the new developments in the field of DNA and RNA vaccines, such as initiatives to enhance and develop delivery systems that are essential to the efficacy of treatments better delivery device design, find the best delivery locations, and personalize cancer immunotherapy through vaccines.
Audience Take Away Notes:
- Attendees will gain a comprehensive understanding of how DNA and RNA vaccines work, including the key differences and similarities between them. This will enhance their knowledge of vaccine technologies and their role in combating both hereditary and acquired diseases
- The presentation will explain the challenges associated with vaccine delivery, particularly for DNA vaccines, and explore emerging methods to improve delivery system design, targeting, and efficacy
- Will learn how DNA and RNA vaccines are being used to personalize cancer immunotherapy, offering tailored treatments based on the genetic makeup of tumors. This could open new avenues for their research or clinical practice
- The presentation will highlight advancements in vaccine design, including the use of novel delivery devices and identification of optimal delivery sites. This will be relevant for those involved in designing more effective vaccines, enhancing both research and practical applications
